FGC
TXMD icon

Financial Gravity Companies’s TherapeuticsMD TXMD Stock Holding History

Financial Gravity Companies’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$0 Buy
+1
New +$244 ﹤0.01% 1521
2018
Q1 		$1K Buy
4
+1
+33% +$281 ﹤0.01% 1274
2017
Q4 		$1K Buy
+3
New +$835 ﹤0.01% 1237

Other funds holding TXMD

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Financial Gravity Companies's TXMD Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in TherapeuticsMD (TXMD) in Q4 2018: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in TXMD as recently as Q1 2018.

Financial Gravity Companies first reported a position in TXMD in Q4 2017 and has held it in 3 quarters since. The position peaked at $1K in Q1 2018. 140 funds tracked by Wall St. Rank hold TXMD as of Q4 2018.

  • Financial Gravity Companies held 1 share of TherapeuticsMD worth $0 as of Q4 2018.
  • TherapeuticsMD was a new Financial Gravity Companies position in Q4 2018.
  • TherapeuticsMD made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1521 holding.
  • Financial Gravity Companies first reported a position in TherapeuticsMD in Q4 2017 and has held it in 3 quarters since.
  • Financial Gravity Companies's TherapeuticsMD position peaked at $1K in Q1 2018.
  • 140 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.